SCHEMBL3976499

SCHEMBL3976499

N#Cc1c(O)ccc(C(=O)OC(=O)c2occ(-c3ccccc3)c2CN2CCCCC2)c1C(=O)NN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
RCE1 Q9Y256 1/20 0.43
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
IKBKB O14920 5/20 0.37
KLK7 P49862 1/20 0.37
GAA P10253 1/20 0.37
POLB P06746 1/20 0.36
CD274 Q9NZQ7 2/20 0.34
TRPV1 Q8NER1 2/20 0.34
USP2 O75604 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
NR4A1 P22736 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3985231 0.87 ALDH1A1 (0.34) ALDH1A1HPGDGAA
SCHEMBL3980870 0.87 IKBKB (0.34) KDM4EALDH1A1HPGDHSD17B10RCE1
SCHEMBL3977121 0.86 ALDH1A1 (0.36) KDM4EALDH1A1HPGDGAAPOLB
SCHEMBL3975937 0.83 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL3978604 0.81 TDP1 (0.32) KDM4EALDH1A1GAAPOLBSMN1; SMN2
SCHEMBL3974765 0.80 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL3976570 0.80 GAA (0.32) ALDH1A1HPGDGAA
SCHEMBL3977604 0.79 ALDH1A1 (0.33) ALDH1A1HPGDIKBKBGAAPOLB
SCHEMBL3978191 0.79 ALDH1A1 (0.35) KDM4EALDH1A1HPGDHSD17B10CASP1
SCHEMBL3978288 0.78 ALDH1A1 (0.34) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 KDM4E 2769/4885ALDH1A1 1389/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.